LETROZOL AMAROX 2.5MG FTA Amarox

6,71 20,13 

SKU: N/A Category:

Description

Indications for LETROZOL AMAROX 2.5MG FTA Amarox

Adjuvant therapy of hormone-positive invasive early breast cancer in postmenopausal women.
Extended adjuvant therapy of early-stage breast cancer in postmenopausal women who have received standard adjuvant tamoxifen therapy for 5 years.
First-line therapy in women with hormone-dependent advanced breast cancer in postmenopausal women.
Treatment of advanced breast cancer in postmenopausal women (natural or artificially induced) after recurrence or progression of disease who have received prior anti-estrogen therapy.
Neoadjuvant therapy in postmenopausal women with hormone-positive, HER-2-negative breast cancer who are not suitable for chemotherapy and are not indicated for urgent surgical intervention.
The efficacy of the drug for patients with hormone-negative breast cancer has not been proven.

Contraindications

  • Hypersensitivity to the active substance or to any other component of the drug.
  • Endocrine status characteristic of premenopausal period.
  • Pregnancy, lactation period.
  • Women of reproductive age.

Additional information

substance active

letrozole

Amount of substance, mg

2.5

formulaire de discharge

compressed

1 compressed, mg

2.5

Plaquettes thermoformed by package, pieces

3

manufacturer

AMAROX PHARMA GmbH

volume de commande

1 blister of 10 compresses, 1 pack (3 blisters)

Reviews

There are no reviews yet.

Be the first to review “LETROZOL AMAROX 2.5MG FTA Amarox”

Your email address will not be published. Required fields are marked *

Select options This product has multiple variants. The options may be chosen on the product page